Coherus BioSciences
Healthcare & Life Sci
Company overview
Coherus BioSciences is a biopharmaceutical company based in the United States. It develops immuno-oncology combination therapies that target the tumor microenvironment to treat cancer. Its main product is LOQTORZI (toripalimab-tpzi), an FDA-approved antibody treatment for nasopharyngeal carcinoma. The company also has other cancer treatments in clinical development. Historically, the median salary is ~$185,000. Coherus BioSciences is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- United States